Advances Business Intelligence and Performance Management Capabilities, Extends IMS One Platform in Europe
DANBURY, Conn.--(BUSINESS WIRE)--
IMS Health (NYSE:IMS) has acquired Forcea, a leading Belgium-based
provider of business intelligence applications and analytics, to advance
performance management capabilities for hospitals and life sciences
organizations around the globe. The acquisition brings together IMS
Health’s comprehensive information and technology services with Forcea’s
hospital-based technology solutions to drive more effective clinical and
cost decisions. Forcea solutions will leverage IMS One, the
company’s intelligent cloud-based platform that seamlessly provisions
industry information and integrates IMS Health, client and third-party
data for faster, more insightful decision making. Financial terms of the
transaction were not disclosed.
With this acquisition, IMS Health further strengthens its leadership in
business intelligence capabilities focused on enabling better care
coordination and improved operating performance. Since 2006, Forcea has
worked closely with hospitals, life sciences companies and other
industry stakeholders in Europe to deliver strategic advisory services
and analytics that include data warehousing implementation, benchmarking
and mobile solutions. IMS Health’s global footprint and Forcea’s
performance management applications will accelerate the delivery of
mission-critical, customizable insights to improve outcomes and support
the ongoing transformation of healthcare systems.
“For life sciences organizations and providers, the challenge today is
to connect and coordinate insights that make vast amounts of information
more actionable and healthcare systems more cost efficient – all while
improving patient care,” said Alistair Grenfell, president, North
Europe, IMS Health. “Forcea’s deep technical expertise and
hospital-based business intelligence capabilities complement our
extensive information assets and experience in helping clients better
analyze data, visualize opportunities and drive measurable performance
gains.”
As healthcare information becomes more connected locally, regionally and
globally, IMS Health is empowering a growing set of clients worldwide to
apply health informatics to improve patient outcomes and better manage
the total cost of care.
“Advancing healthcare quality through technology innovation is a goal
that we share with IMS Health, and we’re very excited to join that
team,” said Frank Swaelens, co-founder and managing partner at Forcea.
“There is a growing demand within the European Union for solutions that
enable more efficient use of healthcare resources and establish
performance benchmarks. Together, our teams are uniquely poised to
support clients with meaningful, evidence-based analysis that is
critical to more insightful healthcare.”
Additional information about Forcea is available at www.forcea.be.
Forward-looking Statements
This press release includes “forward-looking statements” made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995 including statements we make regarding expected
benefits from the Forcea acquisition. The words “believes,” “expects,”
“may,” “will” and similar expressions are intended to identify
forward-looking statements, although not all forward-looking statements
contain these identifying words. Forward-looking statements are not
guarantees that the future results, plans, intentions or expectations
expressed or implied will be achieved. Matters subject to
forward-looking statements involve known and unknown risks and
uncertainties, including regulatory, competitive and other factors,
which may cause actual financial or operating results or the timing of
events to be materially different than those expressed or implied by
forward-looking statements. Important factors that could cause or
contribute to such differences include, but are not limited to, our
ability to successfully integrate Forcea, and the factors set forth in
the “Risk Factors” section of our registration statement on Form S-1 on
file with the SEC and any subsequent SEC filings. We disclaim any
obligation to update any forward-looking statements as a result of
developments occurring after the date of this press release, and you
should not rely on those statements as representing our views as of any
date subsequent to the date of this press release.
About IMS Health
IMS Health is a leading global information and technology services
company providing clients in the healthcare industry with comprehensive
solutions to measure and improve their performance. By applying
sophisticated analytics and proprietary application suites hosted on the IMS
One intelligent cloud, the company connects more than 10 petabytes
of complex healthcare data on diseases, treatments, costs and outcomes
to help its clients run their operations more efficiently. Drawing on
information from 100,000 suppliers, and on insights from more than 45
billion healthcare transactions processed annually, IMS Health’s
approximately 10,000 employees drive results for healthcare clients
globally. Customers include pharmaceutical, consumer health and medical
device manufacturers and distributors, providers, payers, government
agencies, policymakers, researchers and the financial community.
Additional information is available at www.imshealth.com.
As a global leader in protecting individual patient privacy, IMS Health
uses anonymous healthcare data to deliver critical, real-world disease
and treatment insights. These insights help biotech and pharmaceutical
companies, medical researchers, government agencies, payers and other
healthcare stakeholders to identify unmet treatment needs and understand
the effectiveness and value of pharmaceutical products in improving
overall health outcomes.
IMSFIN
Source: IMS Health